Evercore ISI analyst Michael Newshel maintained a Buy rating on Anthem on Wednesday, setting a price target of $335, which is approximately 12.67% below the present share price of $383.59.
Newshel expects Anthem to post earnings per share (EPS) of $6.80 for the third quarter of 2021.
The current consensus among 15 TipRanks analysts is for a Strong Buy rating of shares in Anthem, with an average price target of $429.47.
The analysts price targets range from a high of $465 to a low of $335.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $32.39 billion and a net profit of $0. The company's market cap is $93.92 billion.
According to TipRanks.com, Evercore ISI analyst Michael Newshel is currently ranked with 3 stars on a 0-5 stars ranking scale, with an average return of 6.1% and a 61.90% success rate.
Indiana-based Anthem, Inc. was formed in 2004 after the merger of WellPoint (NYSE:ANTM) Health Networks Inc. and Anthem, Inc. The company is one of the leading health insurance names, and provides medical benefits through a range of integrated healthcare plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, dental, vision, behavioral health benefit services, as well as long-term care insurance and flexible spending accounts.